Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received ...

Clinical studies have demonstrated that both biosimilars are comparable in safety and efficacy to the reference product, the ...

Biocon said that Biocon Biologics has received marketing authorisations from UK Medicines and Healthcare products Regulatory Agency for Vevzuo and Evfraxy, biosimilars of Denosumab.

The Indian market is expected to remain stable on Monday, influenced by global market trends. Nifty futures showed a slight ...

The committee, led by Dr C N Ravindranath, Director of the Sri Jayadeva Institute of Cardiovascular Sciences and Research, ...

On the contrary, a report submitted by the panel said Covid-19 vaccination has been shown to be protective against cardiac ...

Bengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on ...

Nestle India, M&M, Axis Bank, Bharat Forge, Biocon, Central Bank, Escorts, Tech Mahindra, DCB Bank, and Mac Healthcare are ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...

India’s top CEOs come from varied educational backgrounds. Their stories offer inspiration to students and professionals ...

Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marketing authorisation in the European Union (EU).

Karanjot Singh Khurana, Prachi Bharadwaj, and Vrinda Agrawal of Lakshmikumaran & Sridharan analyse the tax deduction ...